Concepedia

Nathaniel W. Oswald

NW

5

Publications

392

Citations

5

H-Index

2012

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

Nathaniel W. Oswald is an author at The University of Texas Southwestern Medical Center specializing in drug development, natural sciences, and molecular pharmacology.

Top concepts

Publications per year

2012–2018

5

Publications

5

Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan

Chensu Wang, Hanspeter Niederstrasser, Peter M. Douglas et al. · Nature Communications · 2017 · 151 citations · Full text

Ikarugamycin: A Natural Product Inhibitor of Clathrin‐Mediated Endocytosis

Sarah R. Elkin, Nathaniel W. Oswald, Dana Kim Reed et al. · Traffic · 2016 · 84 citations · Full text

Precursor-directed generation of amidine containing ammosamide analogs: ammosamides E–P

Ende Pan, Nathaniel W. Oswald, Aaron G. Legako et al. · Chemical Science · 2012 · 77 citations · Full text

, , +19

HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress

Brandt A. Nichols, Nathaniel W. Oswald, Elizabeth A. McMillan et al. · Cancer Research · 2018 · 64 citations · Full text

FUSION-Guided Hypothesis Development Leads to the Identification of N6,N6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor

Rachel M. Vaden, Nathaniel W. Oswald, Malia B. Potts et al. · Marine Drugs · 2017 · 16 citations · Full text

Rows per page

1–5 of 5